Jea Yu, Contributing Author at MarketBeat

Articles by Jea Yu - Page 3

March 12, 2025 5:45 AM ET

3 Retail Giants React to Tariffs—What It Means for Consumers

Jea Yu

The Trump Tariffs have gone into effect with 25% import tariffs on Canada and Mexico and another 10% on China. Here's what the CEOs of top retailers are saying.

NYSE:TGTNYSE:BBYNYSE:GPS

March 12, 2025 5:30 AM ET

Rockwell Automation Poised to Gain From U.S. Tariffs & Onshoring

Jea Yu

Rockwell Automation supplies industrial automation products like robots to factories and stands to benefit from the onshoring effects of the Trump Tariffs.

NYSE:ROKNYSE:ORCLNYSE:TSM

March 11, 2025 6:36 AM ET

Moderna: 4 Key Reasons the CEO Just Bought $5M in Shares

Jea Yu

Moderna stock has fallen to levels not seen in 5 years, but the CEO just spent $5 million buying stock in the open market underscoring his optimism for gains.

NASDAQ:MRNANYSE:MRK

March 11, 2025 6:22 AM ET

Walgreens Boots Alliance: Don’t Write Off This Asset Champ Yet

Jea Yu

Walgreens Boots Alliance agreed to an $11.45 per share buyout by Sycamore Partners, but shareholders can reject the deal and holdout for a better offer.

NASDAQ:WBANYSE:CVS

March 10, 2025 9:02 AM ET

Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors

Jea Yu

Novo Nordisk slashed prices on its GLP-1 obesity drugs as it launches NovoCare to gain compounded GLP-1 users as the compounding labs face deadlines to cease.

NYSE:NVONYSE:LLYNYSE:HIMS

March 10, 2025 7:51 AM ET

S&P 500 & Nasdaq Hit Critical Support—Will Stocks Hold or Fall?

Jea Yu

The S&P 500 and Nasdaq 100 benchmark indexes have fallen to this widely followed support level, where it has bounced 3 and 2 times, respectively, will it again?

NYSEARCA:SPYNASDAQ:QQQNASDAQ:AAPL

March 6, 2025 5:00 AM ET

2 Must-Have Stocks as Consumers Prioritize Needs Over Wants

Jea Yu

Consumers are having to tamp down on spending again as inflation and economic uncertainty cause them to divert spending from wanted to needed items.

NYSE:PGNYSE:KONASDAQ:PEP

March 5, 2025 6:34 AM ET

2 Energy Stocks to Play Both Sides of Tariff Uncertainty

Jea Yu

Import tariffs on Mexico and Canada for 25% and an additional 10% on China has investors scrambling for shelter from the fallout, here's 2 stocks that can.

NYSE:CVENYSE:PSXNYSE:NRG

March 5, 2025 6:27 AM ET

Raytheon vs. Lockheed Martin: Which Stock Has More Upside?

Jea Yu

Defense stocks fell on fears of defense budget cuts as President Trump attempts to halt the wars in Ukraine and Israel, but one stock is more diversified to win

NYSE:LMTNYSE:RTX

March 5, 2025 6:02 AM ET

Grab Holdings: Time to Grab More of This Rideshare Beast

Jea Yu

Grab is the largest rideshare operator in Southeast Asia and only with a 5% penetration of its nearly 700 million person population, which leaves a long runway.

NASDAQ:GRABNYSE:UBER

March 4, 2025 6:07 AM ET

Mediterranean Growth Monster: CAVA Keeps Surging—Buy the Dip?

Jea Yu

CAVA Group posted amazing 21% YoY same restaurant sales in Q4, crushing Chipotle's 5.4% and Sweetgreen's 4% comps growth, yet shares fell 10% in reaction.

NYSE:CAVANYSE:CMGNYSE:SG

March 4, 2025 5:33 AM ET

Boeing Stock Is Edging Out Airbus Again, Here’s How

Jea Yu

Boeing has been in a recovery after a disaster filled 2024 and its recent metrics for January 2025 indicate they edged out oligopoly rival Airbus once again.

NYSE:BAOTCMKTS:EADSY

February 28, 2025 5:30 AM ET

3 Stocks Using Bitcoin to Grow Their Treasury Reserves

Jea Yu

Bitcoin has become more accepted in the mainstream as companies start to incorporate it into their treasury strategy following the template set by MicroStrategy

NASDAQ:ARLPNASDAQ:SMLRNASDAQ:MOGO

February 27, 2025 6:00 AM ET

Builders FirstSource Is Laying the Foundation for a Rebound

Jea Yu

Builders FirstSource is trading at low valuations but its 30+ acquisitions since 2020 has helped grow its moat throughout the nation's geographies.

NYSE:BLDRNYSE:HDNYSE:LOW

February 27, 2025 5:30 AM ET

Regeneron: Is It the Perfect Biotech Stock for Value and Growth?

Jea Yu

Regeneron is trading at historically low valuations as its Dupixent blockbuster drug could get a 30% increase in TAM if the FDA approves its use in COPD.

NASDAQ:REGNNYSE:LLYNYSE:NVO

February 27, 2025 5:15 AM ET

3 Stocks Powering the Future of Autonomous Driving

Jea Yu

Robotaxis are on their way as the new administration will accelerate their arrival, but these autonomous vehicles need key components to operate smoothly.

NASDAQ:MBLYNYSE:APTVNASDAQ:LAZR

February 27, 2025 5:00 AM ET

2 Stocks Riding the Dominance of America’s Natural Gas Exports

Jea Yu

The United States is the leading producer and exporter of liquefied natural gas (LNG) and natural gas exports, here are two companies helping sustain the lead.

NYSE:LNGNYSE:AR

February 26, 2025 5:49 AM ET

Viking Therapeutics: Could GLP-1 Maker Be Acquired Pre-Approval?

Jea Yu

Viking Therapeutics stock jumped on rumors of a potential acquirer looking to add a GLP-1 treatment to their portfolio and VK2735 appears to rival Zepbound.

NASDAQ:VKTXNYSE:PFEOTCMKTS:RHHBY

February 25, 2025 6:37 AM ET

2 Safe-Haven Stocks Shielded From Import Tariffs

Jea Yu

Import tariffs are hitting headlines daily, and Wall Street investors are nervous, but two safe-haven stocks can quell some of the anxiety.

NASDAQ:EXCNASDAQ:GT

February 25, 2025 5:37 AM ET

The Behemoth BlackRock’s Next Trillion Comes From Private Assets

Jea Yu

BlackRock has $10.6 trillion in assets under management (AUM) making them the largest asset manager on the planet, and they are still scaling for more growth.

NYSE:BLKNYSE:STTNASDAQ:IBIT

February 24, 2025 7:16 AM ET

3 Beaten Down Healthcare Stocks Recovering in 2025

Jea Yu

Healthcare stocks took a tumble in 2024 as rising medical costs did a number on margins and profitability, but 2025 may be the year they rebound.

ASX:CVSNYSE:CVSNYSE:ARDT

February 22, 2025 6:16 AM ET

DuPont’s Electronics Spinoff: The Start of Something Big

Jea Yu

DuPont initially sought to split into 3 public companies, but will instead keep the Water division and speed up the spin-off of its Electronic division in Nov

NYSE:DDNYSE:MMMNYSE:HUN

February 22, 2025 5:15 AM ET

Gilead Sciences: 4 Reasons This Stock Has Much More To Rise

Jea Yu

Gilead Pharmaceuticals is back to highs not seen in a decade as its HIV treatment franchise surges and awaits its 100% effective HIV prevention drug in summer

NASDAQ:GILDNYSE:ABBV

February 20, 2025 6:45 AM ET

Humana Gains Despite Medicare Advantage Losses—What’s the Catch?

Jea Yu

Humana is the second largest health insurance provider of Medicare Advantage (MA) plans sounding the alarms of rising medical costs but will now cut 10%

NYSE:HUMNYSE:CVSNYSE:UNH

Page 3 of 86

« Most Recent ‹ More Recent 1 2 3 4 5 6 7 Earlier › Earliest »

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Jea Yu, Contributing Author at MarketBeat

Articles by Jea Yu - Page 3

3 Retail Giants React to Tariffs—What It Means for Consumers

Rockwell Automation Poised to Gain From U.S. Tariffs & Onshoring

Moderna: 4 Key Reasons the CEO Just Bought $5M in Shares

Walgreens Boots Alliance: Don’t Write Off This Asset Champ Yet

Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors

S&P 500 & Nasdaq Hit Critical Support—Will Stocks Hold or Fall?

2 Must-Have Stocks as Consumers Prioritize Needs Over Wants

2 Energy Stocks to Play Both Sides of Tariff Uncertainty

Raytheon vs. Lockheed Martin: Which Stock Has More Upside?

Grab Holdings: Time to Grab More of This Rideshare Beast

Mediterranean Growth Monster: CAVA Keeps Surging—Buy the Dip?

Boeing Stock Is Edging Out Airbus Again, Here’s How

3 Stocks Using Bitcoin to Grow Their Treasury Reserves

Builders FirstSource Is Laying the Foundation for a Rebound

Regeneron: Is It the Perfect Biotech Stock for Value and Growth?

3 Stocks Powering the Future of Autonomous Driving

2 Stocks Riding the Dominance of America’s Natural Gas Exports

Viking Therapeutics: Could GLP-1 Maker Be Acquired Pre-Approval?

2 Safe-Haven Stocks Shielded From Import Tariffs

The Behemoth BlackRock’s Next Trillion Comes From Private Assets

3 Beaten Down Healthcare Stocks Recovering in 2025

DuPont’s Electronics Spinoff: The Start of Something Big

Gilead Sciences: 4 Reasons This Stock Has Much More To Rise

Humana Gains Despite Medicare Advantage Losses—What’s the Catch?

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Jea Yu, Contributing Author at MarketBeat

Articles by Jea Yu - Page 3

3 Retail Giants React to Tariffs—What It Means for Consumers

Rockwell Automation Poised to Gain From U.S. Tariffs & Onshoring

Moderna: 4 Key Reasons the CEO Just Bought $5M in Shares

Walgreens Boots Alliance: Don’t Write Off This Asset Champ Yet

Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors

S&P 500 & Nasdaq Hit Critical Support—Will Stocks Hold or Fall?

2 Must-Have Stocks as Consumers Prioritize Needs Over Wants

2 Energy Stocks to Play Both Sides of Tariff Uncertainty

Raytheon vs. Lockheed Martin: Which Stock Has More Upside?

Grab Holdings: Time to Grab More of This Rideshare Beast

Mediterranean Growth Monster: CAVA Keeps Surging—Buy the Dip?

Boeing Stock Is Edging Out Airbus Again, Here’s How

3 Stocks Using Bitcoin to Grow Their Treasury Reserves

Builders FirstSource Is Laying the Foundation for a Rebound

Regeneron: Is It the Perfect Biotech Stock for Value and Growth?

3 Stocks Powering the Future of Autonomous Driving

2 Stocks Riding the Dominance of America’s Natural Gas Exports

Viking Therapeutics: Could GLP-1 Maker Be Acquired Pre-Approval?

2 Safe-Haven Stocks Shielded From Import Tariffs

The Behemoth BlackRock’s Next Trillion Comes From Private Assets

3 Beaten Down Healthcare Stocks Recovering in 2025

DuPont’s Electronics Spinoff: The Start of Something Big

Gilead Sciences: 4 Reasons This Stock Has Much More To Rise

Humana Gains Despite Medicare Advantage Losses—What’s the Catch?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools